Zhaoming Wang

Nov 7, 2024 | nature.com | Zhaoming Wang |Jinghui Zhang

AbstractOver the past decade, genome-scale molecular profiling of large childhood cancer survivorship cohorts has led to unprecedented advances in our understanding of the genetic and epigenetic bases of therapy-related adverse health outcomes in this vulnerable population.

Sep 4, 2023 | nature.com | Sonja I. Berndt |Nicola J. Camp |Zhaoming Wang |Henrik Hjalgrim |Caroline Besson |Lindsay Morton | +26 more

Correction to: Leukemia https://doi.org/10.1038/s41375-022-01711-0, published online 22 October 2022In this article Arjan Diepstra at affiliation Department of Pathology and Medical Biology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands was missing from the author list. The original article has been corrected. About this articleBerndt, S.I., Vijai, J., Benavente, Y. et al.

May 26, 2023 | nature.com | Jianxin Shi |Kouya Shiraishi |Jiyeon Choi |Tzu-Yu Chen |Juncheng Dai |Rayjean J. Hung | +61 more

AbstractLung adenocarcinoma is the most common type of lung cancer. Known risk variants explain only a small fraction of lung adenocarcinoma heritability. Here, we conducted a two-stage genome-wide association study of lung adenocarcinoma of East Asian ancestry (21,658 cases and 150,676 controls; 54.5% never-smokers) and identified 12 novel susceptibility variants, bringing the total number to 28 at 25 independent loci.